SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001596770-16-000115
Filing Date
2016-02-16
Accepted
2016-02-16 10:31:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - BELLEROPHON 2-11-16 schedule13g.htm SC 13G 259292
  Complete submission text file 0001596770-16-000115.txt   260769
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650-475-3734
VENROCK ASSOCIATES IV L P (Filed by) CIK: 0001277997 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88741 | Film No.: 161424323
SIC: 2834 Pharmaceutical Preparations